151 related articles for article (PubMed ID: 25691007)
1. Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane.
Fantappiè O; Sassoli C; Tani A; Nosi D; Marchetti S; Formigli L; Mazzanti R
J Cell Mol Med; 2015 Jun; 19(6):1410-7. PubMed ID: 25691007
[TBL] [Abstract][Full Text] [Related]
2. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.
Fantappiè O; Masini E; Sardi I; Raimondi L; Bani D; Solazzo M; Vannacci A; Mazzanti R
Hepatology; 2002 Apr; 35(4):843-52. PubMed ID: 11915030
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
Fantappiè O; Solazzo M; Lasagna N; Platini F; Tessitore L; Mazzanti R
Cancer Res; 2007 May; 67(10):4915-23. PubMed ID: 17510421
[TBL] [Abstract][Full Text] [Related]
4. P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines.
Solazzo M; Fantappiè O; Lasagna N; Sassoli C; Nosi D; Mazzanti R
Exp Cell Res; 2006 Dec; 312(20):4070-8. PubMed ID: 17027968
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
[TBL] [Abstract][Full Text] [Related]
6. [Expressions and significance of COX-2 and P-gp in human hepatocellular carcinoma tissues].
Li B; Liu Y; Su S; Zhang MY; Yuan Q; Chen C; Xia XM; Liu CA; Gong JP
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):755-8. PubMed ID: 22409848
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
Lasagna N; Fantappiè O; Solazzo M; Morbidelli L; Marchetti S; Cipriani G; Ziche M; Mazzanti R
Cancer Res; 2006 Mar; 66(5):2673-82. PubMed ID: 16510587
[TBL] [Abstract][Full Text] [Related]
8. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line.
Roy KR; Reddy GV; Maitreyi L; Agarwal S; Achari C; Vali S; Reddanna P
Cancer Chemother Pharmacol; 2010 Apr; 65(5):903-11. PubMed ID: 19685055
[TBL] [Abstract][Full Text] [Related]
10. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
[TBL] [Abstract][Full Text] [Related]
12. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
13. [Reversion of drug-resistant hepatocellular carcinoma cell line BEL-7402/FU by sorafenib].
Wei L; Su N; Zheng DY; Cao MR; Li AM; Yan X; Lü CW; Luo RC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):344-7. PubMed ID: 19351508
[TBL] [Abstract][Full Text] [Related]
14. Guggulsterone sensitized drug-resistant human hepatocarcinoma cells to doxorubicin through a Cox-2/P-gp dependent pathway.
Xu HB; Fu J; Huang F; Yu J
Eur J Pharmacol; 2017 May; 803():57-64. PubMed ID: 28342979
[TBL] [Abstract][Full Text] [Related]
15. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
16. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
Yang JY; Luo HY; Lin QY; Liu ZM; Yan LN; Lin P; Zhang J; Lei S
World J Gastroenterol; 2002 Aug; 8(4):644-9. PubMed ID: 12174371
[TBL] [Abstract][Full Text] [Related]
17. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
18. [Intercellular transfer of P-glycoprotein in hepatocellular cell line HepG2].
Chen L; Zuo GQ; Wu JF; Zeng GL; Li T; Liu ZJ; Tang KF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):839-42. PubMed ID: 19958644
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression.
Ye CG; Wu WK; Yeung JH; Li HT; Li ZJ; Wong CC; Ren SX; Zhang L; Fung KP; Cho CH
Cancer Lett; 2011 May; 304(2):90-6. PubMed ID: 21377266
[TBL] [Abstract][Full Text] [Related]
20. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
Tsang WP; Kwok TT
Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]